PubMed Health⌕ Search

Biomedical subjects

J Stoffregen

Publications and source records attributed to J Stoffregen.

At least 19 recordsLinked to original sources
PubMed1985

[The therapeutic system, CODIC].

CODIC-COmputeriseD Infusion Control is the first universally applicable therapeutic system which can be programmed by the user. CODIC consists of a monitoring unit for IMED 929 infusion pump. It is the first open therapeutic system in the "no demand" mode which is not only programmed but can also be programmed and modified by the user. This makes it universally applicable. It was mainly developed for highly effective drugs with a narrow therapeutic range and short half-life. CODIC opens up possibilities for the optimisation of advanced drug therapy which had not existed so far (e.g. cytostatics). If operated in the "on demand" mode via a pushbutton pressed down by the patient according to individual requirements by analgesic boluses, CODIC provides freedom from pain (not only postoperatively). The fixed-programme infusion profile prevents excess dosage. The same applies to pain relief during child birth. CODIC has been in routine use by the author for the last two years, especially for the automatic monitoring of infusions of Tramadol, Nalbuphin or NLA substances in combination anaesthesia, or in controlled hypotension with nitroprusside.

Computers↗
PubMed1980

[Infusion-controlled Tramal-anaesthesia (author's transl)].

The author reports a new technique of balanced anaesthesia using a pump-controlled 0.1% solution of Tramadol instead of the inhalation of halothane, enflurane or infusion of neuroleptanalgetic agents. Tramadol (Tramal) is a new analgetic drug without side effects: no postnarcotic respiratory depression, sickness or vomiting do not occur, and it does not interfere with the cardiovascular system. The other great advantage is the ultrashort recovery of the patient, mostly with 30-60 s, even after long lasting surgical procedures over several hours. The author has been convinced for more than 15 years that the future of anaesthesia no longer lies in the inhalation of chloroformoids, but in the infusion of analgesic substances. His experience has shown that the analgesic drug Tramadol, which has practically no side-effects, is a considerable advance into this direction. Last but not least this also applies to the prompt post-anaesthetic recovery and the absence of postoperative complications. This technique has been used in the last two years in 7500 patients, So far we have not seen an contraindications to Tramadol infusion. On the contrary, the greater the risk, the more this form of anaesthesia was found to be indicated.

Anesthesia↗